Study to assess the improvement with Soap PUVA therapy, a form of phototherapy wherein UVA rays are used in treating patients with psoriasis

Pilot study to observe the efficacy of Soap PUVA therapy in the treatment of psoriasis - Soap PUVA

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2019/03/018008

Enrollment

Registered

2019-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients of both sexes and age above 18 years. 2) Patients with psoriasis involving > 20% Body surface area 3) Patients with no systemic therapy for past 4 weeks or topical therapy for past 2 weeks 4) Patients not on any systemic drugs known to exacerbate psoriasis 5) Patients willing to give consent

Exclusion criteria

Exclusion criteria: 1) Pregnant and lactating women 2) Patients on systemic treatment 3) Patients with photosensitivity dermatitis or on photosensitising drugs 4) Pustular psoriasis/ erythrodermic psoriasis/unstable psoriasis

Design outcomes

Primary

Measure	Time frame
Reduction in the PASI score (Psoriasis Area Severity Index) which shall indicate the improvement and hence the efficacy of Soap PUVA in psoriasisTimepoint: PASI scoring shall be done at the time of enrollment and then after every 3rd sitting of Soap PUVA for 4 weeks	—

Secondary

Measure	Time frame
To assess the remission time and adverse effects associated with Soap PUVA therapyTimepoint: At the end of 4 weeks	—

Countries

India

Contacts

Public ContactDr Varsha M Shetty

Kasturba Medical College, Manipal Academy of Higher Education, Manipal

drsbpai@yahoo.co.in9900405072

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026